BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25112708)

  • 1. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression.
    Molina-Infante J; Rivas MD; Hernandez-Alonso M; Vinagre-Rodríguez G; Mateos-Rodríguez JM; Dueñas-Sadornil C; Perez-Gallardo B; Ferrando-Lamana L; Fernandez-Gonzalez N; Bañares R; Zamorano J
    Aliment Pharmacol Ther; 2014 Oct; 40(8):955-65. PubMed ID: 25112708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.
    Moawad FJ; Schoepfer AM; Safroneeva E; Ally MR; Chen YJ; Maydonovitch CL; Wong RK
    Aliment Pharmacol Ther; 2014 Mar; 39(6):603-8. PubMed ID: 24461332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of eotaxin-3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor-responsive oesophageal eosinophilia and gastro-oesophageal reflux disease.
    Moawad FJ; Wells JM; Johnson RL; Reinhardt BJ; Maydonovitch CL; Baker TP
    Aliment Pharmacol Ther; 2015 Jul; 42(2):231-8. PubMed ID: 26011446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.
    Cheng E; Zhang X; Huo X; Yu C; Zhang Q; Wang DH; Spechler SJ; Souza RF
    Gut; 2013 Jun; 62(6):824-32. PubMed ID: 22580413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences.
    Eluri S; Dellon ES
    Curr Opin Gastroenterol; 2015 Jul; 31(4):309-15. PubMed ID: 26039722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.
    Dellon ES; Speck O; Woodward K; Covey S; Rusin S; Gebhart JH; Chen X; Woosley JT; Shaheen NJ
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2015-22. PubMed ID: 24993367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.
    Molina-Infante J; Bredenoord AJ; Cheng E; Dellon ES; Furuta GT; Gupta SK; Hirano I; Katzka DA; Moawad FJ; Rothenberg ME; Schoepfer A; Spechler SJ; Wen T; Straumann A; Lucendo AJ;
    Gut; 2016 Mar; 65(3):524-31. PubMed ID: 26685124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis.
    Molina-Infante J; Katzka DA; Gisbert JP
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1157-64. PubMed ID: 23656497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oesophageal narrowing on barium oesophagram is more common in adult patients with eosinophilic oesophagitis than PPI-responsive oesophageal eosinophilia.
    Podboy A; Katzka DA; Enders F; Larson JJ; Geno D; Kryzer L; Alexander J
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1168-77. PubMed ID: 27028344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia.
    Iwakura N; Fujiwara Y; Tanaka F; Tanigawa T; Yamagami H; Shiba M; Tominaga K; Watanabe T; Iijima K; Koike T; Walls AF; Arakawa T
    Aliment Pharmacol Ther; 2015 Apr; 41(8):776-84. PubMed ID: 25693747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.
    Wen T; Dellon ES; Moawad FJ; Furuta GT; Aceves SS; Rothenberg ME
    J Allergy Clin Immunol; 2015 Jan; 135(1):187-97. PubMed ID: 25441638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.
    Dellon ES; Speck O; Woodward K; Gebhart JH; Madanick RD; Levinson S; Fritchie KJ; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2013 Dec; 108(12):1854-60. PubMed ID: 24145677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA sequencing confirms similarities between PPI-responsive oesophageal eosinophilia and eosinophilic oesophagitis.
    Peterson KA; Yoshigi M; Hazel MW; Delker DA; Lin E; Krishnamurthy C; Consiglio N; Robson J; Yandell M; Clayton F
    Aliment Pharmacol Ther; 2018 Jul; 48(2):219-225. PubMed ID: 29863285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon.
    Savarino EV; Tolone S; Bartolo O; de Cassan C; Caccaro R; Galeazzi F; Nicoletti L; Salvador R; Martinato M; Costantini M; Savarino V
    Aliment Pharmacol Ther; 2016 Sep; 44(5):522-30. PubMed ID: 27373195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton-pump inhibitor-responsive esophageal eosinophilia.
    Molina-Infante J; Katzka DA
    Curr Opin Gastroenterol; 2014 Jul; 30(4):428-33. PubMed ID: 24837227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
    Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
    J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia.
    Gómez-Torrijos E; García-Rodríguez R; Castro-Jiménez A; Rodríguez-Sanchez J; Méndez Díaz Y; Molina-Infante J
    Aliment Pharmacol Ther; 2016 Feb; 43(4):534-40. PubMed ID: 26662868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia.
    Park JY; Zhang X; Nguyen N; Souza RF; Spechler SJ; Cheng E
    PLoS One; 2014; 9(7):e101391. PubMed ID: 24988451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of proton pump inhibitor therapy in the management of eosinophilic esophagitis.
    Molina-Infante J; Prados-Manzano R; Gonzalez-Cordero PL
    Expert Rev Clin Immunol; 2016 Sep; 12(9):945-52. PubMed ID: 27097787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.